Zabrina L. Brumme
St. Paul's Hospital
Vancouver, BC, Canada
Vancouver, BC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 174 publications
HIV superinfection reveals sequential reservoir reactivation and immune-driven rebound dynamics.
Journal: Journal of virology
Published: July 10, 2026
Getting to the root of HIV transmitted founder virus sequences.
Journal: Virus evolution
Published: October 15, 2025
Prolonged non-suppressible viremia sustained by a clonally expanded, genomically defective provirus with an immune-evasive HIV protein expression profile.
Journal: bioRxiv : the preprint server for biology
Published: June 04, 2025
Investigation of Integrase Inhibitor Resistance Mutations in gp41 in Clinical Samples.
Journal: Journal of acquired immune deficiency syndromes (1999)
Published: May 13, 2025
Computational and Population-Based HLA Permissiveness to HIV Drug Resistance-Associated Mutations.
Journal: Pathogens (Basel, Switzerland)
Published: January 30, 2025
Genetic determinants of HIV-1 subtype C Nef-mediated SERINC3 down-regulation.
Journal: Virology journal
Published: November 28, 2024
A simple phylogenetic approach to analyze hypermutated HIV proviruses reveals insights into their dynamics and persistence during antiretroviral therapy.
Journal: Research square
Published: July 01, 2024
No detectable differences in Nef-mediated downregulation of HLA-I and CD4 molecules among HIV-1 group M lineages circulating in Cameroon, where the pandemic originated.
Journal: Frontiers in virology (Lausanne, Switzerland)
Published: June 17, 2024
Sustained virologic suppression of multidrug-resistant HIV in an individual treated with anti-CD4 domain 1 antibody and lenacapavir.
Journal: Nature medicine
Published: June 12, 2024
A simple phylogenetic approach to analyze hypermutated HIV proviruses reveals insights into their dynamics and persistence during antiretroviral therapy.
Journal: Virus evolution
Published: June 08, 2024
Autologous HIV-specific T cell therapy targeting conserved epitopes is well-tolerated in six adults with HIV: an open-label, single-arm phase 1 study.
Journal: Nature communications
Published: June 04, 2024
Last Updated: 09/26/2026